During your first consultation with an Affinity Medical Provider, you go over your lab results and medical history together
As the dose increases from 1 mg to 8 mg, the incidence of persons with gut issues nearly doubles, demonstrating a distinct connection to higher dosage
Reduced dietary intake, combined with potential alterations in gut absorption from GLP-1 gastrointestinal effects, can create deficiencies in both
Pair Saxenda with lifestyle modifications
For diabetes patients, A1c reductions of approximately 1.0-1.5 percentage points are common with GLP-1 receptor agonists, while tirzepatide has shown reductions of up to 2.0-2.3 percentage points in clinical trials
Tirzepatide's SURMOUNT programme tops out lower at comparable durations [1]